Join the club for FREE to access the whole archive and other member benefits.
Monopolist Aspen got the opportunity to raise the price of essential NHS medicine by 1,800 per cent
Key points from article :
Collusion by three pharmaceutical firms has resulted in price rises for a life-saving drug purchased by the NHS.
Thousands of patients rely on fludrocortisone to treat what is known as Addison’s disease.
Aspen will pay the NHS £8m to resolve another competition issue related to the supply of fludrocortisone.
Click on resource name for more details.
Company focused on a broad range of post-patent, branded medicines, and domestic brands spanning many therapeutic areas
